Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Department of Endocrinology, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
PLoS One. 2023 Jun 14;18(6):e0286743. doi: 10.1371/journal.pone.0286743. eCollection 2023.
Protein tyrosine phosphatase, nonreceptor type 22 (PTPN22), is an archetypal non-HLA autoimmunity gene. It is one of the most prominent genetic contributors to type 1 diabetes mellitus outside the HLA region, and prevalence of its risk variants is subject to enormous geographic variability. Here, we address the genetic background of patients with type 1 diabetes mellitus of Armenian descent. Armenia has a population that has been genetically isolated for 3000 years. We hypothesized that two PTPN22 polymorphisms, rs2476601 and rs1310182, are associated with type 1 diabetes mellitus in persons of Armenian descent. In this association study, we genotyped the allelic frequencies of two risk-associated PTPN22 variants in 96 patients with type 1 diabetes mellitus and 100 controls of Armenian descent. We subsequently examined the associations of PTPN22 variants with the manifestation of type 1 diabetes mellitus and its clinical characteristics. We found that the rs2476601 minor allele (c.1858T) frequency in the control population was very low (q = 0.015), and the trend toward increased frequency of c.1858CT heterozygotes among patients with type 1 diabetes mellitus was not significant (OR 3.34, 95% CI 0.88-12.75; χ2 test p > 0.05). The control population had a high frequency of the minor allele of rs1310182 (q = 0.375). The frequency of c.2054-852TC heterozygotes was significantly higher among the patients with type 1 diabetes mellitus (OR 2.39, 95% CI 1.35-4.24; χ2 test p < 0.001), as was the frequency of the T allele (OR 4.82, 95% CI 2.38-9.76; χ2 test p < 0.001). The rs2476601 c.1858CT genotype and the T allele correlated negatively with the insulin dose needed three to six months after diagnosis. The rs1310182 c.2054-852CC genotype was positively associated with higher HbA1c at diagnosis and 12 months after diagnosis. We have provided the first information on diabetes-associated polymorphisms in PTPN22 in a genetically isolated Armenian population. We found only a limited contribution of the prototypic gain-of-function PTPN22 polymorphism rs2476601. In contrast, we found an unexpectedly close association of type 1 diabetes mellitus with rs1310182.
蛋白质酪氨酸磷酸酶,非受体型 22(PTPN22)是典型的非 HLA 自身免疫基因。它是 HLA 区域外导致 1 型糖尿病的最主要遗传因素之一,其风险变异体的流行率存在巨大的地理变异性。在这里,我们研究了亚美尼亚裔 1 型糖尿病患者的遗传背景。亚美尼亚的人口已经遗传隔离了 3000 年。我们假设两个 PTPN22 多态性,rs2476601 和 rs1310182,与亚美尼亚裔人群的 1 型糖尿病有关。在这项关联研究中,我们对 96 名 1 型糖尿病患者和 100 名亚美尼亚裔对照者的两种风险相关 PTPN22 变体的等位基因频率进行了基因分型。随后,我们检查了 PTPN22 变体与 1 型糖尿病的发病及其临床特征的关联。我们发现,在对照组中,rs2476601 次要等位基因(c.1858T)的频率非常低(q = 0.015),而 1 型糖尿病患者中 c.1858CT 杂合子的频率呈增加趋势,但无统计学意义(OR 3.34,95%CI 0.88-12.75;卡方检验,p>0.05)。对照组中 rs1310182 的次要等位基因(c.2054-852TC)的频率较高(q = 0.375)。在 1 型糖尿病患者中,c.2054-852TC 杂合子的频率明显更高(OR 2.39,95%CI 1.35-4.24;卡方检验,p<0.001),T 等位基因的频率也更高(OR 4.82,95%CI 2.38-9.76;卡方检验,p<0.001)。rs2476601 的 c.1858CT 基因型和 T 等位基因与诊断后 3-6 个月所需的胰岛素剂量呈负相关。rs1310182 的 c.2054-852CC 基因型与诊断时和诊断后 12 个月的 HbA1c 较高呈正相关。我们首次提供了在遗传隔离的亚美尼亚人群中与糖尿病相关的 PTPN22 多态性的信息。我们只发现了原型功能获得性 PTPN22 多态性 rs2476601 的有限作用。相反,我们发现 1 型糖尿病与 rs1310182 密切相关,这令人意外。